Properties of metrics applied for the evaluation of bioequivalenceJIUHONG ZHA; TOTHFALUSI, L; ENDRENYI, L et al.Drug information journal. 1995, Vol 29, Num 3, pp 989-996, issn 0092-8615Conference Paper

Variability and Impact on Design of Bioequivalence StudiesVAN PEER, Achiel.Basic & clinical pharmacology & toxicology (Print). 2010, Vol 106, Num 3, pp 146-153, issn 1742-7835, 8 p.Conference Paper

Statistical evaluation of individual bioequivalenceLIU, J.-P.Communications in statistics. Theory and methods. 1998, Vol 27, Num 6, pp 1433-1451, issn 0361-0926Conference Paper

Application of Williams' design for bioequivalence trialsMOHANDOSS, E; SHEIN-CHUNG CHOW; KI, F. Y. C et al.Drug information journal. 1995, Vol 29, Num 3, pp 1029-1038, issn 0092-8615Conference Paper

Current issues of individual bioequivalenceANDERSON, S.Drug information journal. 1995, Vol 29, Num 3, pp 961-964, issn 0092-8615Conference Paper

Etudes sur la biodisponibilité et la bioéquivalence = Study on biovailability and bioequivalenceJUNGINGER, H. E.S.T.P. pharma. 1988, Vol 4, Num 6, pp 504-508Article

A moment-based criterion for determining individual bioequivalenceHOLDER, D. J; HSUAN, F.Drug information journal. 1995, Vol 29, Num 3, pp 965-979, issn 0092-8615Conference Paper

Controversies in bioequivalence studiesSTEINIJANS, V. K; HAUSCHKE, D; JONKMAN, J. H. G et al.Clinical pharmacokinetics. 1992, Vol 22, Num 4, pp 247-253, issn 0312-5963Article

On the assessment of bioequivalence in a two-period cross-over designWIJNAND, H. P.Computer methods and programs in biomedicine. 1992, Vol 37, Num 2, pp 151-157, issn 0169-2607Article

Sample size determination : extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43DILETTI, E; HAUSCHEKE, D; STEINIJANS, V. W et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1992, Vol 30, Num 8, pp 287-290, issn 0174-4879Conference Paper

The vasoconstrictor assay in bioequivalence testing : practical concerns and recent developmentsSTOUGHTON, R. B.International journal of dermatology. 1992, Vol 31, pp 26-28, issn 0011-9059, SUP1Conference Paper

Critical considerations into the new EMA guideline on bioequivalenceMARZO, Antonio; FONTANA, Elena.Arzneimittel-Forschung. 2011, Vol 61, Num 4, pp 207-220, issn 0004-4172, 14 p.Article

Metabolites and bioequivalence: Past and presentJACKSON, Andre J; ROBBIE, Gabriel; MARROUM, Patrick et al.Clinical pharmacokinetics. 2004, Vol 43, Num 10, pp 655-672, issn 0312-5963, 18 p.Article

European Congress of Biopharmaceutics and PharmacokineticsAIACHE, J.-M; BALANT, L; HADDOCK, B. A et al.European journal of drug metabolism and pharmacokinetics. 1996, Vol 21, Num 2, issn 0378-7966, 127 p.Conference Proceedings

Bio-international 94, conference on bioavailability, bioequivalence and pharmacokinetic studies. Pre-Conference Satellite on in vivo/in vitro correlationBLUME, H. H; MCGILVERAY, I. J; MIDHA, K. K et al.European journal of pharmaceutical sciences. 1995, Vol 3, Num 2, pp 113-124, issn 0928-0987Conference Proceedings

Assessing the bioequivalence of biosimilars : The Retacrift® caseSCHELLEKENS, H.Drug discovery today. 2009, Vol 14, Num 9-10, pp 495-499, issn 1359-6446, 5 p.Article

Generic antiarrhythmic drugs : What constitutes equivalency ?BENDITT, D. G.Journal of interventional cardiac electrophysiology (Print). 1999, Vol 3, Num 2, pp 145-147, issn 1383-875XArticle

Some observations on current and possible future developments in bioequivalency testingRHODES, C. T.Drug development and industrial pharmacy. 1999, Vol 25, Num 4, pp 559-562, issn 0363-9045Article

Prescribability and switchability of highly variable drugs and drug productsMIDHA, K. K; RAWSON, M. J; HUBBARD, J. W et al.Journal of controlled release. 1999, Vol 62, Num 1-2, pp 33-40, issn 0168-3659Conference Paper

Bias of two one-sided tests procedures in assessment of bioequivalenceJEN-PEI LIU; CHUNG-SING WENG.Statistics in medicine. 1995, Vol 14, Num 8, pp 853-861, issn 0277-6715Article

A comparative study of confidence interval and confidence region methods in determination of bioequivalence between two formulationsHSING-CHU HSU; HAI-LIN LU; CHI, T. C et al.Drug information journal. 1995, Vol 29, Num 3, pp 1021-1028, issn 0092-8615Conference Paper

Les généripues: L'avis du pharmaeologuePATHA, Atul.Diabète & obésité. 2012, Vol 7, Num 63, pp 318-320, issn 1957-5238, 3 p.Article

Bioequivalence revisited: Influence of age and sex on CYP enzymesBEBIA, Zourab; BUCH, Shama C; WILSON, John W et al.Clinical pharmacology and therapeutics. 2004, Vol 76, Num 6, pp 618-627, issn 0009-9236, 10 p.Article

Individual bioequivalence : Attractive in principle, difficult in practiceENDRENYI, L; AMIDON, G. L; MIDHA, K. K et al.Pharmaceutical research. 1998, Vol 15, Num 9, pp 1321-1325, issn 0724-8741Article

The transitivity of bioequivalence testing : potential for driftANDERSON, S; HAUCK, W. W.International journal of clinical pharmacology and therapeutics. 1996, Vol 34, Num 9, pp 369-374, issn 0946-1965Article